Association between high von Willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes

Kidney International

Volumn 57, Issue 4, 2000, Pages 1437-1443

  Lacquemant, Corinne ^a,b,c,d,e,f   Gaucher, Christine ^a,b,c,d,e,f   Delorme, Catherine ^a,b,c,d,e,f   Chatellier, Gilles ^a,b,c,d,e,f   Gallois, Yves ^a,b,c,d,e,f   Rodier, Michel ^a,b,c,d,e,f   Passa, Philippe ^a,b,c,d,e,f   Balkau, Beverley ^a,b,c,d,e,f   Mazurier, Claudine ^a,b,c,d,e,f   Marre, Michel ^a,b,c,d,e,f   Froguel, Philippe ^a,b,c,d,e,f   Bouallouche, Abderamane ^e   Galtier, Florence ⁱ   Bringer, Jacques ⁱ   Bouhanick, Beatrice ⁱ   Sert, Caroline ^g   Grimaldi, André ^g   Dusselier, Laurent ⁱ   Crea, Thérèse ⁱ   Drouin, Pierre ⁱ   Kahal, Z Zoubida ⁱ   Simon, Dominique ⁱ   Chaillous, Lucy ⁱ   Charbonnel, Bernard ⁱ   Muller, Anne ⁱ   Marechaud, Richard ⁱ   Halimi, Serge ⁱ   Sackmann, Henry ⁱ   Tauber, Jean Pierre ⁱ   Mayaudon, Hervé ⁱ   Bauduceau, Bernard ⁱ   Paquot, Nicolas ⁱ   Scheen, André ⁱ   Miossec, Patrick ⁱ   Attali, Jean Raymond ⁱ   Cerf, Isabelle ⁱ   Charpentier, Guillaume ⁱ   Thivolet, Charles ⁱ   Tielmans, Dominique ^h   Guillausseau, Pierre Jean ^h   Poirer, Jean Yves ⁱ   Allanic, Hubert ⁱ   Tichet, J ⁱ   more..

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

^b HÔPITAL BROUSSAIS   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d NÎMES UNIVERSITY HOSPITAL   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f INSERM   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h HÔPITAL LARIBOISIÈRE   (France)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR 8; CREATININE; DNA; VON WILLEBRAND FACTOR;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DNA POLYMORPHISM; FEMALE; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR;

EID: 0034029009     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00988.x     Document Type: Conference Paper

References (32)

1. 1. ANDERSEN AR, CHRISTIANSEN JS, ANDERSEN JK, KREINERS, DECKERT T: Diabetic nephropathy in type I (insulin dependent) diabetes: An epidemiological study. Diabetologia 25:496-501, 1983
2. 2. KROLEWSKI AS, WARRAM JH, RAND LI, KAHN CR: Epidemiological approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 317:1390-1398, 1987
3. 3. STAESSEN JA, WANG JG, GINOCCHIO G, PETROV V, SAAVEDRA AP, SOUBRIER F, VLIETINCK R, FAGARD R: The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular renal risk. J Hypertens 15:1579-1592, 1997
4. 4. FUJISAWA T, IKEGAMI H, KAWAGUCHI Y, HAMADA Y, UEDA H, SHINTANI M, FUKUDA M, OGIHARA T: Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41:47-53, 1998
5. 5. LORENZI M, CAGLIERO E: Pathobiology of endothelial and other vascular cells in diabetes mellitus. Diabetes 40:653-659, 1991
6. 6. RUGGERI ZM, WARE J: The structure and function of von Willebrand factor. Thromb Haemost 67:594-599, 1992
7. 7. JENSEN T: Increased plasma concentration of vWF in insulin dependent diabetics with incipient nephropathy. Br Med J 298:27-28, 1989
8. 8. STEHOUWER CDA, STROES ESG, HACKENG WHL, MULDER PGH, DEN OTTOLANDER GJH: vWF and development of diabetic nephropathy in IDDM. Diabetes 40:971-976, 1991
9. 9. BENSOUSSAN D, LEVY-TOLEDANO S, PASSA PH, CAEN J, CANIVET J: Platelet hyperaggregation and increased plasma level of vWF in diabetics with retinopathy. Diabetologia 11:307-312, 1975
10. 10. PORTA M: vWF as an indicator of endothelial cell dysfunction in diabetic microangiopathy: Studies in vivo. Diabetes Metab 14:523-526, 1988
11. 11. JANSSON J-H, NILSSON TK, JOHNSON O: vWF in plasma: A novel risk factor for recurrent myocardial infarction and death. Br Heart J 66:351-355, 1991
12. 12. THOMPSON SG, KIENAST J, PYKE SDM, HAVERKATE F, VAN DE LOO JCW: Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 332:635-641, 1995
13. 13. BORCH-JOHNSEN K, KREINER S: Proteinuria: Value as predictor of cardiovascular mortality in insulin-dependent diabetes. Br Med J 294:1651-1654, 1987
14. 14. MYRUP B, MATHIESEN ER, RONN B, DECKERT T: Endothelial function and serum lipids in the course of developing microalbuminuria in insulin-dependent diabetes mellitus. Diabetes Res 26:33-39, 1994
15. 15. STEHOUWER CDA, FISCHER HRA, VAN KUIJK AWR, POLAK BCP, DONKER AJM: Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes 44:561-564, 1995
16. 16. MARRE M, JEUNEMAITRE X, GALLOIS Y, RODIER M, CHATELLIER G, SERI C, DUSSELIER L, KAHAL Z, CHAILLOUS L, HALIMI S, MULLER A, SACKMAN H, BAUDUCEAU B, BLED F, PASSA PH, ALHENC-GELAS F: Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 99:1585-1595, 1997
17. 17. BLACKBURN H: Classification of the electrocardiogram for populations studies: Minnesota code. J Electrocardiol 2:305-310, 1969
18. 18. LIE RF, SCHMITZ JM, PIERRE KJ, GOCHMAN N: Cholesterol oxidase-based determination by continuous flow analysis of total and free cholesterol in serum. Clin Chem 22:1627-1630, 1976
19. 19. GALLOIS Y, VOLS S, CALES E, BALKAU B, THE DESIR SIUDY GROUP: Distribution of fasting serum insulin, measured by enzyme immunoassay, in an unselected population of 4032 individuals, references values, according to age and sex. Diabetes Metab 22:427-431, 1996
20. 20. SADLER JE, GINSBURG D: A database of polymorphisms in the von Willebrand factor gene and pseudogene. Thromb Haemost 69:185-191, 1993
21. 21. MERCIER B, GAUCHER C, MAZURIER C: An Msp I polymorphism in the von Willebrand factor gene. Nucleic Acids Res 18:7467, 1990
22. 2, in Statistical Methods in Medical Research (2nd ed), Oxford, Blackwell Scientific Publication Oxford, 1990, pp 469-472
23. 23. ORCHARD TJ, DORMAN JS, MASER RE, BECKER DJ, DRASH AL, ELLIS D, LAPORTE RE, KULLER LH: Prevalence of complications in IDDM by sex and duration: Pittsburgh Epidemiology Diabetes Complications Study II. Diabetes 39:1116-1124, 1990
24. 24. LAW M, WALD N: Why heart disease mortality is low in France: The time lag explanation. Br Med J 318:1471-1480, 1999
25. 25. HEYWOOD DM, MANSFIELD MW, GRANT PJ: Levels of von Willebrand factor, insulin resistance syndrome, and a common vWF gene polymorphism in non-insulin-dependent (type 2) diabetes mellitus. Diabet Med 13:720-725, 1996
26. 26. RODEGHIERO F, CASTAMAN G, DINI E: Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 69:454-459, 1987
27. 27. GILL JC, ENDRES-BROOKS J, BAUER PJ, MARKS WJ, MONTGOMERY RR: The effect of ABO blood group on the diagnosis of vWD. Blood 69:1691-1695, 1987
28. 28. MAZURIER C: von Willebrand disease masquerading as Haemophilia A. Thromb Haemost 67:391-396, 1992
29. 29. KRONER PA, FOSTER PA, FAHS SA, MONTGOMERY RR:The defective interaction between von Willebrand factor and factor VIII in a patient with type I von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor. Blood 87:1013-1021, 1996
30. 30. KEIGHTLEY AM, LAM YM, BRADY JN, CAMERON CL, LILLICRAP D: Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: Identification of three novel single nucleotide polymorphisms in the vWF gene promoter. Blood 93:4277-4283, 1999
31. 31. TOOKE JE: Microvascular function in human diabetes: A physiological perspective. Diabetes 44:721-726, 1995
32. 32. NIEVELSTEIN PFEM, SIXMA JJ, OTTENHOF-ROVERS M, WYNNE HJ, DE GROOT PG, DIRK BANGA J: Platelet adhesion and aggregate formation in type I diabetes under flow conditions. Diabetes 40:1410-1417, 1991